Literature DB >> 30929381

[How I treat primary myelofibrosis].

Z J Xiao1.   

Abstract

Entities:  

Year:  2019        PMID： 30929381     DOI： 10.3760/cma.j.issn.0253-2727.2019.03.002

Source DB:  PubMed          Journal:  Zhonghua Xue Ye Xue Za Zhi        ISSN： 0253-2727


× No keyword cloud information.
  2 in total

1.  [The anti-proliferative and anti-inflammatory mechanisms of JAK1 inhibitor SHR0302 versus Ruxolitinib in SET2 cell line and primary cells].

Authors:  A Y Yang; J Q Liu; Y N Cai; M Y Fang; L Yang; M Chen; B Li; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2019-12-14

2.  [Genetic characteristics and prognostic values of RAS mutations in patients with myelofibrosis].

Authors:  J Y Wu; B Li; Y J Jia; P H Zhang; Z F Xu; T J Qin; S Q Qu; L J Pan; J Q Liu; X Yan; Y D Zhang; J Chen; J Y Gong; Z J Xiao
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2020-12-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.